Goldman Sachs’s Direxion Daily Pharmaceutical & Medical Bull 3X ETF PILL Stock Holding History

Goldman Sachs’s Portfolio PILL Stock Details PILL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-18,132	Closed	-$196K	–	6468
2022 Q2	$196K	Sell	18,132 -21,649	-54%	-$242K	﹤0.01%	5650
2022 Q1	$576K	Sell	39,781 -54,760	-58%	-$737K	﹤0.01%	5224
2021 Q4	$1.5M	Buy	+94,541	New	+$1.65M	﹤0.01%	4497

Other funds holding PILL

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs's PILL Position: Q3 2022 in Review

Goldman Sachs sold out of Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) in Q3 2022, closing a stake of 18,132 shares — an estimated $196K sold.

Goldman Sachs first reported a position in PILL in Q4 2021 and held it in 3 quarters. The position peaked at $1.5M in Q4 2021. 2 funds tracked by Wall St. Rank hold PILL as of Q3 2022.

Goldman Sachs reported no remaining Direxion Daily Pharmaceutical & Medical Bull 3X ETF position as of Q3 2022 after selling out during the quarter.
Goldman Sachs sold 18,132 Direxion Daily Pharmaceutical & Medical Bull 3X ETF shares in Q3 2022, an estimated $196K.
Goldman Sachs first reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in Q4 2021 and held it in 3 quarters.
Goldman Sachs's Direxion Daily Pharmaceutical & Medical Bull 3X ETF position peaked at $1.5M in Q4 2021.
2 funds tracked by Wall St. Rank held Direxion Daily Pharmaceutical & Medical Bull 3X ETF as of Q3 2022.

Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.